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Significance for Public Health 
The use and exposure of asbestos has historically caused human suffering and still represents 
a global public health issue. Asbestos-related disease includes asbestosis, lung cancer, 
malignant mesothelioma which results in innumerable disability, associated societal costs 
and deaths. The lag time between exposure and the development of disease may be up to 3 
decades, thus the follow up of vulnerable population should be considered a public health 
objective to prevent these diseases. Over 67 countries in the world have adopted a national 
ban on asbestos; but in Latin America only 6. This paper describes several aspects of actual 
policies, focusing both on regulatory aspects and monitoring strategies. We encourage to 
keep working together government, workers, industry advocates, environmentalists, 
clinicians, scientists, and consumers; to diminish the impact of this preventable disease, an 




Only six countries have banned the industrial use of asbestos in Latin America and the 
Caribbean. In fact, the industrial use of asbestos appears to be growing in this region. 
Asbestos is one of the most dangerous natural substances in the world, it is contained in 
several types of rocks (such as serpentinites, mafic and ultramafic rocks) but fibers can be 
released to the atmosphere both by natural and antropogenic sources. Six countries have 
banned the industrial use of asbestos in this region, we expected that laws established before 
2007 would be less adherent to the 2007 WHO/ILO recommendations. In contrast, the 
Chilean law of 2001 is one of those that most adheres to international recommendations along 
with the Colombian law of 2021. Which means that the newest laws are not necessarily the 
strongest. This article aims to draw a regional overview of the laws against asbestos 
production in Latin America and the Caribbean, highlighting the strengths and weaknesses 
of each national policy. We recommend that countries that have already banned asbestos 
consider updating and strengthening their existing laws and develop clinical guidelines for 
the management, monitoring, and rehabilitation of asbestos-related diseases. The challenge 
of asbestos goes far beyond a prohibition law. 
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Introduction 
Asbestos is made up of a group of fibrous materials used in construction and other industries 
due to its chemical properties and low price. In addition to the environmental damage caused 
by the process of extraction and production of the material, exposure to asbestos is a known 
cause of occupational health diseases, including pleural mesothelioma, which causes 
thousands of deaths worldwide, 26.278 in 2020 with a mortality crude rate 0.4 per 100.0001,2. 
Since asbestos is classified as carcinogenic to humans by the international agency for 
research on cancer3, many international efforts have been made in recent decades to ban the 
production of asbestos, requiring healthcare workers, policy makers, and other stakeholders 
to work together across the globe. As a result of this multilateral approach to the problem, 
the industrial use of asbestos has so far been banned in more than 67 countries4. The World 
Health Organization (WHO) in association with the International Labor Organization (ILO) 
established the broad lines of programs to eliminate asbestos-related diseases in 20075. 
Despite the WHO in association with the ILO established the broad lines of programs to 
eliminate asbestos-related diseases in 20075, about 125 million people are exposed to 
asbestos in the workplace worldwide6.  
Only six countries have banned the industrial use of asbestos in Latin America and the 
Caribbean, and not all have banned its production throughout the national territory. In fact, 
the industrial use of asbestos appears to be growing in this region. This raises concerns about 
the impact of international directives in this region and the expected long-term benefit of 
current interventions. This article aims to draw a regional overview of the laws against 
asbestos production in Latin America and the Caribbean, highlighting the strengths and 
weaknesses of each national policy, to identify barriers and opportunities for improvement 
of each one. We strongly believe that this document will also help raise awareness among 
policy makers, healthcare providers and physicians living in countries that have not 






Asbestos can be defined as a group of natural minerals, known since ancient times; multiple 
historical references show it7. Asbestos are silicates of iron, sodium, magnesium, and 
calcium, with a crystalline structure, made up of very fine microscopic fibers in the shape of 
a needle or measures that reach a length greater than 5 microns, diameter less than 3 microns 
and a length/diameter ratio greater than 38. Among its characteristics we have a remarkable 
durability, resistance to traction and flexibility, resistance to heat, wear, alkalis, and acids; 
Value-conferring properties in a wide range of products, including pipe and building 
insulation, friction products including brake shoes, and fire-resistant bricks9. It has been 
woven in fire retardant fabric and incorporated into erosion resistant cement tiles. The 
physical, chemical, and mineralogical properties have contributed to making asbestos one of 
the most suitable and useful materials8. But at the same time, one of the most dangerous 
natural substances in the world, being naturally contained in the rocks it can be released to 
the ambient atmosphere, the hydrosphere, in the soil of many areas and accumulate in the 
lung tissues after occupational exposure10. 
 
To date asbestos had proved dangerous for humans only if inhaled10. Nevertheless, due to 
their small size and low density, asbestos fibers can be transported quickly through wind and 
water and penetrate a variety of ecosystems8,9. Precipitation acts as a collector and introduces 
fibers into the water cycle, strengthening its polluting potential. Streams and groundwater in 
contact with asbestos-containing bedrock are also an important source of asbestos fibers in 
the natural environment. In addition, the common use of fiber cement pipes to transport 
drinking water increases the concentration of this mineral, making it a potential polluting 
factor for humans in urban areas. 
 
Although the effect of asbestos on marine life still requires more research, studies so far have 
shown its ability to accumulate in algae (or phytoplankton), a primary source of the food 
chain8. The alteration of aquatic environments on their primary scale could affect consumers 
at all trophic levels, including herbivores and carnivores. In addition to this negative impact, 
asbestos-rich soils provide unfavorable environments for the growth of vegetation, harboring 
limited plant species and generating a decrease in ecosystem diversity, including animal 
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diversity. Said vegetation is subjected to a significant level of stress, which entails a delay in 
its growth, alterations in the color and development of its roots. 
 
We have also used asbestos in cities as a material for the construction of roads, railways, 
foundations, and other engineering purposes. The transport of these materials generates 
asbestos dust that can reach dangerous levels for the health of the population8. It is also 
known that for every ton of asbestos fiber produced twenty tons of asbestos waste is 
generated, but we do not know how to handle this waste in the mines of Colombia and Latin 
America. 
 
Asbestos has been a fundamental pillar for the industrial growth of many nations, especially 
in developing countries with limited financial resources. Its great attractiveness is due to its 
durability, versatility, cost-effectiveness, and unrefined technology requirements. This was 
compounded by the paucity of health-related information about the risk of its exposure. It 
was not until the 1950s and early 1960s that the British first raised awareness of a direct 
relationship between the manipulation of this mineral and respiratory cancer diseases. By 
then, South America was beginning to boom in the world’s asbestos market and its 
consumption was about 38,100 tons per year. By 1970 Brazil became the most influential 
South American producer and consumer of asbestos, and for 1980s the percentage of the 
world’s total asbestos consumption was: Africa, 80 percent; Asia, 77 percent; Eastern 
Europe, 76 percent; South America, 76 percent; Oceania, 60 percent; North America, 
including the United States, 45 percent; and Western Europe, 43 percent. With the emergence 
of problems related to its use, worldwide consumption declined from 4.73 Mt in 1980 to 
about 2.11 Mt in 2003. Many companies have been forced to stop producing this mineral and 
many others have gone into bankruptcy11.  Regardless, with the prohibitions and regulations, 
European countries began to buy asbestos in South American industries which exponentially 
increased the production in this region in the last 30 years12. 
 
There are two major groups of asbestos: serpentines and amphiboles, the latter are the most 
fibrogenic and carcinogenic. Various pulmonary and extrapulmonary pathologies can be 
caused by this type of fibers. Among the pulmonary ones, we emphasize pleural effusion, 
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pleural plaques, diffuse pleural thickening, asbestosis, rounded atelectasis, lung carcinoma 
and mesothelioma. 
 
Asbestosis is a diffuse interstitial pulmonary fibrosis that occurs especially in patients with a 
clinical history of high levels of exposure over long periods of time, and it involves a process 
of accumulation of inhaled particles that react with the lung’s tissue. At histopathologic 
analysis, asbestos bodies can be identified in intraalveolar macrophages. It presents with 
similar clinical and radiological features as other forms diffuse interstitial pulmonary fibrosis. 
The imaging approach with chest radiography can reveal small irregular opacities with a fine 
reticular pattern and may be associated with pleural thickening or plaques, however there are 
no known pathognomonic findings of asbestosis in this exam. The detection of parietal 
pleural thickening in the CT scan along with lung fibrosis is highly suggestive of asbestos-
induced pulmonary fibrosis and can be very useful in differentiating it from idiopathic 
pulmonary fibrosis13,14. 
 
All forms of asbestos can cause asbestosis, a chronic and irreversible pneumoconiosis. 
Furthermore, they have been shown to be carcinogenic to humans15. Exposure to these fibers, 
especially occupational exposure, results in an increased incidence of mesothelioma and 
cancers of the lung, larynx, and ovary and has shown a limited association with cancers of 
the pharynx, stomach, and colorectal4. Due to the long latencies of asbestos-related 
diseases16, the consequences of asbestos exposure can be observed even after 30-40 years 
and still represent a relevant issue in countries where asbestos was mined during the last 
century17. Monitoring the vulnerable population should be considered a public health 
objective to prevent these diseases. 
 
Asbestos and malignant Pleural Mesothelioma (MPM)  
The data available on MPM are considered a reflex of a sentinel event indicating the effects 
of asbestos exposure. The highest mesothelioma incidence rates are reported from some 
countries in Europe (UK, The Netherlands, Malta, Belgium) and in Oceania (Australia, New 
Zealand). Countries with intermediate incidence rates includes Finland, Norway, Sweden, 
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Denmark, Iceland, Germany, France, Italy, Austria, and the United States. Some other 
countries lack of information, inducing an underestimation of mesothelioma incidence15. It 
is remarkable to mention that inside a given country, MPM incidence shows huge variations 
from one area to another. Generally, these areas are or have been the site of asbestos mines, 
or asbestos industries in which asbestos was largely employed (mainly shipyards and 
asbestos-cement factories).  
MPM have a poor prognosis with a 5-year relative survival of 10%, because up to 65% of 
cases are diagnosed at an advanced stage18. The exact mechanism by which asbestos causes 
MPM is unknown. Nevertheless, some models could explain the carcinogenesis of asbestos: 
1) DNA damage induced by reactive oxygen species produced by asbestos fibers results in 
genetic instability and leads to the development of cancer. 2) Once inside mesothelial cells, 
asbestos fibers induce cell cycle disorders that produce chromosomal abnormalities. 3) 
Asbestos fibers can interfere with the normal function of proteins associated with the cell 
cycle, causing cell damage and dysregulation of the cell cycle. 4) After interaction with 
asbestos fibers, mesothelial cells could release growth factors and pro-inflammatory 
cytokines that induce cell proliferation and survival19. Regardless, nearly 80% of MPM 
patients have a history of previous asbestos exposure, making the causal link between 
asbestos and MPM highly relevant. 
Treatment of MPM depends on the stage of the disease at the time of diagnosis. For the local 
stages, surgery remains the standard treatment. Instead, locoregional disease may require 
multimodal therapy including induction chemotherapy, surgery, and adjuvant radiation 
therapy. Stage IV disease represents a great challenge for the oncologist. For many years, 
cisplatin 75 mg/m2 plus pemetrexed 500 mg/m2 given every 3 weeks has been the preferred 
first-line chemotherapy. In a phase 3 trial, the combination was superior to cisplatin alone 
with an overall survival of 12.1 versus 9.3 months and the toxicity was acceptable20. 
Unfortunately, although the patient responds to this treatment initially, almost everyone will 
have disease progression. So, immunotherapy was the natural option to explore in clinical 
trials for MPM, due to its excellent results in other types of cancer. In fact, the combination 
of nivolumab plus ipilimumab showed a better overall survival of 18.1 versus 14.1 months 
compared to cisplatin/carboplatin plus pemetrexed in a phase III trial, becoming the new 
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standard of treatment for unresectable MPM21. Additionally, there are some ongoing trials 
testing pembrolizumab, durvalumab, and atezolizumab alone or in combination therapy for 
MPM22–24. At this point, it is important to say that immunotherapy is not available in all 
countries. For this reason, platinum-based chemotherapy remains the most widely used 
treatment overall. Interestingly, about 2.4% of MPMs have microsatellite instability (MSI)25. 
The identification of high MSI tumors is clinically relevant, especially since the FDA 
approved the use of pembrolizumab for all types of high MSI solid tumors, which means that 
pembrolizumab could be another treatment option to consider in this population specific.  
 
Regional overview of the laws against asbestos production in Latin America and the 
Caribbean  
Since 1972, many countries have banned the use of asbestos, but it is still mined in 
developing countries. With the aim of reducing the health impact related to asbestos, in 2007 
the WHO, in collaboration with the ILO and other intergovernmental organizations and civil 
society, has provided a series of recommendations26. Among those who highlight the 
importance of stopping the use of all varieties of asbestos. Most countries provide 
information on solutions to replace asbestos with safer substitutes and develop economic and 
technological mechanisms to stimulate its replacement; take steps to prevent asbestos 
exposure on site and during removal; improve early diagnosis, treatment, and rehabilitation 
services; establish records of people with past and/or current exposures and organize medical 
surveillance of exposed workers. Finally, it is critical that countries provide information on 
the hazards associated with asbestos-containing materials and products and create awareness 
that asbestos-containing wastes should be treated as hazardous waste26.  
Now we will expose the laws that some Latin American countries have implemented to 
mitigate this situation, and we will analyze whether these laws adhere to the 2007 WHO/ILO 
recommendations to for the Development of National Programmes for Elimination of 





Asbestos in Argentina, Chile, Uruguay, and Honduras: the first steps  
Argentina 
In 1997, Argentina considered asbestos as a priority within its National Plan for the Rational 
Management of Chemical Substances, and was the subject of analysis by a technical working 
group on carcinogenic substances, in addition to public meetings in which the government, 
the workers, representatives of the industry, universities, environmentalists, scientists and 
consumers, it was agreed that exposure to asbestos constitutes a risk factor for both workers 
and the general population and that this country must provide citizens with the same 
protections adopted by many developed countries27. In 2000, Argentina became the first 
country in Latin America to ban the use of asbestos (Resolution 845), specifically 
amphiboles. One year later, through Resolution 823 of 2001, the production, import, 
commercialization and use of chrysotile variety asbestos fibers and products that contain 
them are prohibited, as of January 1, 200327,28.  
 
Chile 
The Chilean Ministry of Health, through Supreme Decree 656 of January 13, 2001, totally 
prohibits the production, import, distribution, sale and use of all types of asbestos and any 
material or product that contains it28. It should be noted that article 5 of Decree 656 
establishes that: The Health Authority may authorize the use of asbestos in the manufacture 
of products or elements that are not construction materials, provided that the interested parties 
demonstrate that there is no technical or economic feasibility that allows to replace it with 
another material29. Though, this can only be done if strict hygiene and safety measures are 
maintained in the workplace, which will be, in each case, indicated and expressly authorized 
by the competent Health Service, an entity that will verify that the risks to the health of 
workers have been controlled (Article 6). 
 
Uruguay 
Through the implementation of Decree 154 of May 7, 2002, Uruguay restricts the 
manufacture, import and commercialization of asbestos or products that contain it30. 
Specifically, it is established that the manufacture, introduction into the national territory in 
any form and the commercialization of products containing asbestos included in heading 
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6811 and in item 6812.50.00.00 of the NCM (Common Mercosur Nomenclature) is 
prohibited. For the manufacture, introduction to the national territory in any form and 
commercialization of the rest of the products that contain asbestos, a special authorization 
must be requested from the Ministry of Public Health30. To obtain this authorization, the 
manufacturer, introducer, or trader must submit technical reports that indicate the 
characteristics of the products or elements to be introduced into the country to manufacture 
or market, the types of asbestos or asbestos that will be used, the measures that must be 
adopted. to control health risks, how waste will be disposed of and justification that it is not 
possible to replace asbestos with other types of materials31. 
 
Honduras 
Honduras, for its part, through Agreement No. 32-94 of January 16, 2004, implemented a 
provision that prohibits the use of products containing chrysotile, anthophyllite, actinolite, 
amosite and crocidolite, as well as their import, manufacture, distribution, marketing, 
transportation, and storage, excluding thermal or electrical insulation of household 
appliances, electronic equipment, and personal fire protection equipment28. 
 
Asbestos in Brazil: Strong steps. There is still controversy 
Law 9,055 of June 1, 1995, prohibits throughout the national territory the extraction, 
production, industrialization, use and sale of actinolite, amosite, anthophyllite, crocidolite 
and tremolite, mineral varieties belonging to the group of amphiboles, as well as the products 
that contain them, mineral substances; However, this law does not prohibit the use of asbestos 
(variety chrysotile, serpentine minerals), allowing its extraction, use and 
commercialization32. 
In 2007, through Law 12.684 - updated to Law No. 16.048, of December 10, 2015, Brazil 
prohibits in the State of São Paulo, the use of products, materials or devices that contain any 
type of asbestos (variety streamers and amphiboles), or any mixture containing one or more 
of these minerals33. On 01/29/2017, the Federal Supreme Court (STF) decided the total 
abolition of the use of asbestos in all Brazilian states. The National Confederation of 
Industrial Workers (CNTI) filed a direct action of unconstitutionality before the STF, arguing 
that, since Federal Law No. 9055/95 allowed the use of asbestos, several state regulations, 
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including that of Rio de Janeiro, were invading the competence of the Union by imposing 
greater restrictions. The STF ministers did not accept the action, considering that the health 
of the worker is well protected constitutionally and is above any economic interest, for which 
the states are prohibited from adopting laws that liberate the use of asbestos. However, even 
today there is concern about the use of Chrysotile variety asbestos in the country, due to the 
permission contained in Law 9055/95. Since this country has been an important producer and 
importer of this mineral, widely used in the cement and fiber cement industry34. 
 
Asbestos in Colombia: a long way to prohibition  
Asbestos production in Colombia began in 1940 and since then, this mineral has been used 
in the construction, automotive and textile industries35. For decades, Colombia positioned 
itself as one of the most important asbestos producing countries in the region, with mines 
located mainly in the Department of Antioquia. Starting in the eighties, after demonstrating 
the relationship between exposure to asbestos and the development of some lung diseases, 
several countries began to regulate and prohibit the use, exploitation, and commercialization 
of this material. On the contrary, in Colombia, the production and consumption of asbestos 
continued to be predominant. Since 2007, in Colombia, seven bills have been presented in 
the Congress of the Republic that seek to prohibit the use of asbestos without their approval 
being successful (Table 2). Even in 2010, one of the main chrysolite-type asbestoses-
producing mines, Mina Las Brisas, located in Campamento, Antioquia, was reopened, with 
a production of around 700 tons of asbestos per month36; this probably explains the increase 
in national asbestos consumption from 20,000 to 25,200 tonnes between 2011 and 201235. In 
response, different civil society groups tried to ban asbestos through different legislative 
means. This led to the prohibition of the use of asbestos in the municipality of El Colegio, 
Cundinamarca and in the Department of Boyacá throughout the first half of 2019. Finally, in 
June 2019, bill 061/17 was approved, which had been presented since August 2, 2017, by 
Senator Nadia Blel. This bill better known as "The Ana Cecilia Niño Law", in honor of the 
social communicator and victim of exposure to asbestos who led the ban on the mineral in 
Colombia, aims to preserve life, health and the environment of the workers and of all the 
inhabitants of Colombia. The national territory against the risks posed by exposure to 
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asbestos. This by prohibiting the exploitation, production, marketing, distribution, or export 
of any variety of asbestos throughout the national territory, as of January 1, 202136,37. 
Likewise, the law establishes guarantees for exposed workers, through the creation of the 
National Commission for the Substitution of Asbestos, which must ensure effective 
compliance with the substitution of Asbestos; and prepare the Labor Adaptation and 
Productive Reconversion Plan with which it is intended to identify workers affected by 
exposure to asbestos, generate the necessary studies to monitor the health of these workers 
for a period of 20 years, and dictate measures that guarantee relocation of a job. For this, a 
term of 5 years was defined38. 
 
Peru, Paraguay, Bolivia, Venezuela, Panama, Costa Rica: On the way. Regulation is 
different from prohibition 
According to the Pan American Health Organization (PAHO) asbestos atlas project there are 
some countries that are limited to addressing the management of asbestos in a safe way, 
without envisioning its ban. Peru, through law 29662, prohibited the use of amphibole 
asbestos and indicated the demolition and removal of buildings, where due to the time of its 
construction it is presumed the existence of asbestos fiber insulation that could cause 
dispersion of asbestos fibers. Anyhow, it provided accreditation for the regulated use of 
chrysotile asbestos39. Paraguay, Bolivia, and Venezuela do not apply restrictions on its use, 
but it must have the endorsement of the Ministry of the Environment or Health; as well as 
complying with the laws that oblige employers to guarantee the safety and health of 
employees exposed to this mineral. For their part, countries such as Panama and Costa Rica 
have regulations that allow the controlled use of asbestos, ensuring the management and 
protection of personnel, without a clear guideline on prohibition40. 
 
Discussion 
The negative impact of asbestos is irrefutable, and we probably still do not understand the 
enormous scale of damage that can result from its use. Currently, social, cultural, political, 
and environmental challenges must focus on the development of populations whose 
structures do not interfere with the inherent capacity of the earth to generate and sustain all 
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kinds of life. For this, it is important to appreciate public health problems in their immense 
density and interconnection with other sciences.  
Only six countries in Latin America and the Caribbean have legislation on the prohibition of 
asbestos. As common points, the laws prohibit all forms of asbestos throughout the national 
territory, except Brazil where it was initially banned only in the state of Sao Paulo, however 
the STF in 2017 decided the total abolition of the use of asbestos in all states Brazilians32. 
The legislation of Argentina, Chile and Uruguay establishes guidelines based on ILO 
Convention 162 issued in 1986, which determines the measures to be adopted to prevent and 
control health risks due to occupational exposure to asbestos and protect its workers41. In the 
information available on the legislation in Honduras and Brazil, there is no information that 
refers to adherence to ILO Convention 162.  
As particular strengths of the laws on asbestos in Latin America, we highlight the 
establishment of guidelines that follow the model proposed by the WHO/ILO in terms of 
measures to prevent exposure to asbestos in place and during its removal, as well as the 
measures that It will be adopted to protect the health of workers and surrounding populations, 
the substitution of asbestos for safer products, the dangers associated with materials and 
products that contain asbestos, as well as the importance of proper management of the waste 
that contains this material. We also consider very important the presence of guidelines on the 
safe handling of structures with installed asbestos. The best examples are the 'Technical 
Guide for the environmental management of asbestos waste and the products that contain 
them' from Colombia and the 'Manual for the elaboration of a work plan with materials that 
contain friable and non-friable asbestos' from Chile. However, these documents focus 
primarily on structures that require demolition and do not provide an active strategy for 
removing existing structures. Another positive aspect to emphasize is the presence of 
certified private companies that provide safe asbestos removal services in the region, but the 
process can be very expensive, and none of the regional laws provide a concrete economic 
strategy to cover the cost of asbestos removal. 
Surprisingly, we expected that laws established before 2007 would be less adherent to the 
2007 WHO/ILO recommendations. In contrast, we find that the Chilean law of 2001 is one 
of those that most adheres to international recommendations along with the Colombian law 
of 2021. Which means that the newest laws are not necessarily the strongest.  
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In general, a common weakness of the legislation of Latin American countries is that they do 
not establish guidelines regarding the registration or identification of people with past and/or 
current exposures to asbestos, at risk of suffering diseases related to exposure to it. Likewise, 
none of them include limits on asbestos exposure within their guidelines. They all talk about 
gradual withdrawal, controlled use, restrictions on specific conditions or prohibitions. It 
would be recommended that countries that have not yet banned asbestos adopt measures such 
as those established by The Occupational Safety and Health Administration (OSHA) of the 
United States42. These measures include protections such as the Permissible Exposure Limit 
(PEL) and the time weighted average (TWA) to ensure safe and healthful working conditions 
for workers from the hazards of asbestos. 
On the other hand, despite the existence of very complete clinical guidelines, such as the 
Comprehensive Evidence-Based Care Guide for Pneumoconiosis (Silicosis, Pneumoconiosis 
and Asbestosis of the Coal Miner) 2006 (GATI-PNEUMO) and the National Plan for the 
Prevention of Silicosis, Pneumoconiosis and Asbestosis of the Coal Miner 2010-2030 (6.26) 
in Colombia43,44, we found that a guide with concrete recommendations on medical 
surveillance, treatment or rehabilitation of these workers is lacking. It should be noted that 
some documents such as the "norm of the use, management and disposal of asbestos and its 
wastes" in Argentina, established clinical tests and specific follow-up times for exposed 
workers, but even so, they do not include guidelines for treatment and rehabilitation in the 
document. 
The Colombian Law was the last to come into force and therefore the most adherent to the 
WHO/ILO recommendation. Unfortunately, despite being the most complete initiative, it 
does not contemplate some important aspects that were proposed in the bills previously raised 
in the country, such as the cooperation of other countries, which have already implemented 
the ban on asbestos, which could provide advice and technical assistance to Colombia (Bill 
45/07 of the Senate of the Republic)36. 
After reviewing each law, we identified three aspects that we consider opportunities to 
improve these laws that should be considered now that these Laws have entered into force. 
1) The participation of victims and workers in the National Commission for the Substitution 
of Asbestos should be considered. 2) Governments should start educational campaigns, to 
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prevent people without the necessary knowledge and care from trying to remove these 
elements, considering that mishandling of asbestos already installed can cause the release of 
particles from it, thus increasing the risk of exposure. 3) As oncologists, we consider it vitally 
important that a longer period of health follow-up be considered for workers exposed to 
asbestos. This is because, as mentioned above, latency periods longer than 30 years have 
been documented for the development of pathologies secondary to asbestos exposure16. In 
Colombia, a 20-year follow-up period was established. 
In addition, we also advise that countries that do not have an asbestos law become aware of 
the problem and draw on the experience of those countries that already have it, because, as 
we already explained, there is a long way to go to reach the goal. The resistance of the 
asbestos industry is guaranteed and regional problems such as insecurity, low health 
coverage, unemployment and poverty hinder any initiative in general. In this context, we 
recognize that our research is limited, as it cannot conclude whether the existing laws in the 
region are having the expected impact in each country. The introduction of epidemiological 
surveillance systems, such as the mesothelioma registry45, would help to evaluate public 
health policies on the prevention of asbestos-related diseases in the long period. International 
collaborations with public health institution that already manage these tools could be useful 
to increase the awareness about the actual consequences of asbestos exposure. 
 
Conclusions 
As of the date of this publication, the production and commercialization of asbestos continues 
in most of the countries of Latin America and the Caribbean. Only six countries have banned 
the production of asbestos so far. Although other countries have regulated the use of asbestos. 
After reviewing each law, we concluded that the newest laws against Asbestos are not 
necessarily the strongest. Therefore, we recommend that countries that have already banned 
asbestos consider updating and strengthening their existing laws and develop clinical 
guidelines for the management, monitoring, and rehabilitation of asbestos-related diseases.  
Finally, we congratulate the pioneering countries in this initiative, which are setting an 
example for the rest of the region. Howbeit, in our opinion, the challenge of asbestos goes 
far beyond a prohibition law and requires motivated governments working together with 
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Table 1: Regional overview of laws against asbestos production in Latin America and the 
Caribbean. Do they adhere to the 2007 WHO / ILO recommendations? 


















X      X       X X X ü  
National Asbestos 
work plan 




ü  ü  ü  - - ü  
Registry of workers 
exposed to Asbestos 
X      X X X - ü  
Preventing strategies 
for exposed workers 
ü  ü  ü  - ü  ü  
Strategic actions to 
replace asbestos with 
safer substitute 
       X ü  ü  X ü  ü  
Economic strategies to 
cover the cost of 
Asbestos elimination 
process 
      X      X X X X X 
Monitoring and 
evaluation strategy 
      -      - - - - ü  
Apply all over the 
country 
ü  ü  ü  ü  X* ü  
- No information available. *the Federal Supreme Court (STF) decided the total abolition of 








January of 2007 199/07 of the House of 
Representatives 
“Establish and regulate the obligation to produce and supply 
social cement and sheets of asbestos coverage, as an input for 
the plans for the construction or improvement of low-income 
housing and as an incentive to promote low-income housing 
plans and programs managed by the State”. 
July of 2007 35/07 Senate of the 
Republic 
“Prohibit the use of asbestos, in all its forms, in the 
manufacture of all kinds of elements in the national territory.” 
July of 2007 45/07 Senate of the 
Republic 
“Adopt guidelines for the protection policy against asbestos in 
the national territory.” 
November of 
2007 
177/07 Senate of the 
Republic 
“Issue regulations on the prohibition of the use of asbestos in 
all its varieties and establish prevention, protection and 
surveillance measures against the risks derived from exposure 
to asbestos in the workplace and the environment in general”. 
May of 2009 341/09 of the House of 
Representatives 
“Establish and regulate the production and distribution of 
sheets of social cement and fiber cement for roofs.” 
September of 
2015 
97/15 of the House of 
Representatives 
“Prohibit the production, marketing, export, import and 
distribution of any variety of asbestos in Colombia.” 
July of 2016 34/16 of the House of 
Representatives 
“Prohibit the production, marketing, export, import and 
distribution of any variety of asbestos in Colombia.” 
Adapted from: Observatorio de Redes y Acción Colectiva Universidad del Rosario. Asbesto 
¿un peligro silencioso? Parte 2: Intentos de prohibición del uso de asbesto en Colombia. 
2019; 50-54. 
